Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 3 3Phase 1 3Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 718Lung Neoplasms 310Small Cell Lung Carcinoma 111Neoplasms 42Adenocarcinoma of Lung 40Neoplasm Metastasis 35Parkinson Disease 4, Autosomal Dominant Lewy Body 22Brain Neoplasms 21Carcinoma 19Breast Neoplasms 18Lung Diseases 15NSCLC 14Mesothelioma, Malignant 14Thoracic Neoplasms 13Adenocarcinoma, Bronchiolo-Alveolar 13Prostatic Neoplasms 11Pleural Effusion, Malignant 10Non-Squamous Non-Small Cell Lung Cancer 10Mesothelioma 10Cachexia 10Respiratory Tract Neoplasms 9Pain 9Bronchial Neoplasms 9Respiratory Tract Diseases 8Carcinoma, Squamous Cell 8Carcinoma, Bronchogenic 8Adenocarcinoma 8Pancreatic Neoplasms 7Esophageal Neoplasms 7Colonic Neoplasms 7

Interventions

Gemcitabine 2pembrolizumab 1Vinorelbine 1Erlotinib Hydrochloride 1Docetaxel 1Cisplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Advanced Non-Small Cell Lung Cancer × Thoracic × Clear all
NCT06980272 2025-06-24

SSGJ-707 in Advanced Non-Small Cell Lung Cancer

Shenyang Sunshine Pharmaceutical Co., LTD.

Phase 3 Recruiting
420 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT00349219 2016-01-15

TORCH

National Cancer Institute, Naples

Phase 3 Completed
760 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT00345059 2016-01-14

DISTAL-2

National Cancer Institute, Naples

Phase 3 Terminated
84 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡